Pericarditis and pericardial effusion: one or two distinct diseases?


Journal

Minerva cardiology and angiology
ISSN: 2724-5772
Titre abrégé: Minerva Cardiol Angiol
Pays: Italy
ID NLM: 101776555

Informations de publication

Date de publication:
Apr 2022
Historique:
pubmed: 3 8 2021
medline: 14 4 2022
entrez: 2 8 2021
Statut: ppublish

Résumé

The main pericardial syndromes include acute and recurrent pericarditis, constrictive pericarditis, and chronic pericardial effusion in the absence of overt inflammation. Despite recent advances in pericardial syndromes, certain clinical scenarios depict remarkable peculiarities, and their management is often challenging for the clinician. Acute pericarditis is the most common pericardial disease and in most instances is accompanied by pericardial effusion. On the other hand, pericardial effusion may appear as a separate clinical entity occasionally characterized by absence of inflammatory markers elevation. In cases that effusions are accompanied by C-reactive protein (CRP) elevation, the administration of empiric anti-inflammatory treatment as in acute pericarditis, is the guidelines recommended approach. Conversely, the optimal management of patients with pericardial effusions in the absence of clinical or subclinical inflammation (as depicted by CRP levels and cardiac magnetic resonance findings), is not supported by solid evidence. Patients with chronic pericardial effusions should be followed in specialized centers according to tailored timelines, based on the specific clinical scenarios which should consider etiology, effusion size, disease duration and stability as regards symptoms and effusion volume. Patients should also be advised to seek medical care at any time if symptoms like chest pain, dyspnea and fatigue should appear.

Identifiants

pubmed: 34338486
pii: S2724-5683.21.05721-5
doi: 10.23736/S2724-5683.21.05721-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

207-216

Auteurs

George Lazaros (G)

School of Medicine, First Cardiology Clinic, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, Greece - glaz35@hotmail.com.

Emilia Lazarou (E)

School of Medicine, First Cardiology Clinic, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Charalambos Vlachopoulos (C)

School of Medicine, First Cardiology Clinic, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Alexios Antonopoulos (A)

School of Medicine, First Cardiology Clinic, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Konstantinos Tsioufis (K)

School of Medicine, First Cardiology Clinic, Hippokration General Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH